Medically reviewed by Jeffrey S. Lander, MD Key Takeaways Combining blood pressure medications, such as a long-acting calcium channel blocker with an ACE inhibitor or ARB, is often more effective than ...

Ghent, Belgium, 28 April 2026 - Sequana Medical NV(Euronext Brussels: SEQUA) (the "Company" or "SequanaMedical"), a pioneer in the treatment of drug-resistant fluid overload in liver disease, heart ...

SQ Innovation, developer of Lasix® ONYU, today announced two important regulatory milestones in its international expansion strategy: the receipt of a CE marking certificate for the Lasix ONYU device, ...

A scientific statement regarding the evaluation and management of pediatric patients with ADHF has been published by the AHA.

Nationwide overnight delivery from Walmart improves access to novel at-home prescription treatment, with particular benefit for rural communities where transportation and distance are often barriers ...

Cirrhotic ascites is driven by proximal tubular sodium reabsorption, mainly via NHE3. Due to spatial coupling of NHE3 and SGLT2, SGLT2 inhibitors ...

SPIRIT-HF missed its primary composite endpoint at 2 years, with higher observed event rates on spironolactone versus placebo ...

Detailed price information for Esperion Theraptc (ESPR-Q) from The Globe and Mail including charting and trades.

ABSTRACT: Despite substantial advances in guideline-directed medical therapy, recurrent hospitalization remains a persistent challenge in the management of congestive heart failure (CHF). Fluid ...

Esperion plans to leverage its established cardiovascular commercial infrastructure to deploy Enbumyst across specialist offices, outpatient heart failure clinics, and integrated delivery networks. A ...

Little is known about the initial dosing of loop diuretics among patients hospitalized for heart failure and its association with outcomes. Despite decades of experience with intravenous loop ...

The analysis included 120 veterans (66 years and older) who potentially experienced the gabapentinoid-LD prescribing cascade. HealthDay News — The potential downstream harms in the gabapentinoid ...